Breast Lump

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 8

Breast Lump- Dr Deepak Ghuliani- Prepladder (Presenter- Dr Keshav Garg, MAMC

2017)

Demographics

Mrs. XYZ
48/F
R/o Bihar
Daily wage labourer
Low class SES as per MKS
Informant – Self

DOE: 21-07-2021

Chief c/o

She presented to the OPD with chief c/o

1. Lump in the Left Breast x 5 months

HOPI

The patient was apparently well 5 months ago, when she first noticed a lump in her
left breast while bathing
It was insidious in onset and the size has increased rapidly in the last 5 months from 1
x 1 cm initially to 5 x 3 cm at present
Lump is Painless

- No h/o overlying skin changes, nipple retraction and nipple discharge


- No h/o left arm swelling [to detect edema of the limbs]
- No h/o back pain, headache, abnormal body movements, abdominal distention,
breathless, and haemoptysis
- No h/o weight loss
- No h/o similar complaints in the right breast
- No h/o radiation exposure or trauma
- No h/o change in size with menstruation

[Overlying skin changes


- Erythema
- Ulceration
- Peau d’orange
- Satellite nodules

Edema of the limbs – infiltration/metastasis of axillary lymph nodes due to malignant


lump blocks/obstructs lymphatics which can lead to lymphedema – swelling of limb

Nipple Discharge:
Benign Malignant
Bilateral Unilateral
Milky / serous discharge Bloody discharge
Multi-ductal Uni-ductal
On Expression Spontaneous
change in discharge with
menstruation
Past H/o

No H/o similar c/o in the past


No h/o previous surgery or biopsy in either of the breast
No h/o DM, HTN, TB, Asthma, drug allergy

Family H/o

Father has HTN x 20 years well controlled on medication


Mother has DM x 25 years on medication
No H/o breast CA or any other malignancy in any first degree relatives

Obstetrics H/o

- P1L1
- Male child via LSCS at the age of 35 years
- Breastfed up to 1 year of age

Menstrual H/o

- Menarche attained at 15 years


- Regular menstrual cycles, 28 days apart, with 4 days of flow
- LMP: 10-06-2021
- [H/o HRT in post-menopausal female – risk factor for Breast CA]

Personal H/o

- No h/o smoking, alcohol addiction


- Non-veg
- Appetite is reduced
- Sleep inadequate
- Bowel bladder habits normal

Summary of H/o

48 y/o lady presents with mass in left breast x 5 months, which is painless and rapidly
increasing in size to present size of 5 x 3 cm with no symptoms s/o local and distant
spread

D/d
- Breast CA
- Phylloides Tumour [35-50 years, rapid increase in size]
- Breast cyst [40-50 years – due to ANDI – abnormalities in normal development
and involution]

[Points in favour of CA Breast in H/o


- Age
- Painless and Rapidly Progressing
- Risk factor – 1st child at older age – 35 years

Factors that can increase the risk of CA Breast:

- Increased/prolonged duration of Exposure to Estrogen


1. Early menarche < 12 years
2. Late menopause > 55 years
3. Nulliparity
4. Decreased duration/Absence of Breastfeeding
5. Age of Mother at first live birth/first pregnancy > 30 years

History to rule out Local/Distant spread

Local spread
- Skin involvement
- Lymphatic spread – No left limb swelling
Metastasis/Distant spread
- Vertebra – Backache (Bone Pain)
- Liver – hepatomegaly, jaundice, abdominal distention
- Lung – haemoptysis, dyspnea {malignant pleural effusion - dyspnea}
- CNS – headache, convulsions – due to increased ICT ]

EXAMINATION

GPE
- Examination done in well-lit room with patient sitting comfortably on bed,
- Patient is conscious, cooperative, well-oriented to time place and person
- Built- normal; Height – 157 cm; Weight – 52 Kg; BMI: 21.1 kg/m2

Vitals:
- PR: 79/min; BP: 125/78 mmHg; RR: 18/min; Temp: 37 degrees C; JVP not raised
- PICKLE [cervical LN, pedal edema] absent; axillary LN examination discussed in
local O/E

Local Examination

- Patient examined after due verbal informed consent, with adequate privacy, in
the presence of a female attendant, and exposed from neck to umbilicus

Inspection done with


- Arms by the side of the body [compare size and shape of both breasts, level of
nipples, nipple retraction, lump/fullness visible, skin changes, dilated veins,
puckering]
- Arms raised straight above her head [dimpling, infra-mammary area, axillary
tail]
- Patient bending forward from the waist [breast falling forward or not – fixity to
chest wall]
- Sitting with the arms on the waist and pressing on the waist [subtle
retraction/dimpling can become more evident, lumps not visible earlier become
prominent

- Position of both breasts is normal


- Both are symmetrical in shape
- Nipples are at the same level and symmetrical
- Left Breast has a visible lump of 5 x 3 cm in the lower inner quadrant
- with no overlying skin erythema, ulceration, peau d’orange, satellite nodules,
dilated veins
- Nipple areola complex is normal with no nipple retraction, ulceration, or
discharge
- Right breast shows no fullness or lump, has normal skin and normal NAC
- On raising the arms, no visible puckering is present, no visible axillary swelling
and the infra-mammary area is normal.
- On bending forward, both breasts fall forward equally
- On keeping hands over the waist and pressing- no dimpling seen

Examination of supra-clavicular fossa – No swelling/fullness of SCL fossa, no upper


limb edema

Palpation
- Right Breast
o No local rise of temperature, no tenderness
o No lump felt in any quadrant
o No discharge from nipple present
- Left Breast
o No local rise in temperature, no tenderness
o Lump present in the Lower Inner quadrant, globular in shape, 5 x 3 cm in
size, hard in consistency, with irregular surface, irregular and ill-defined
margins
o Fixed to skin, no fixity to underlying muscle
o No nipple discharge present

Lymph node examination- B/L axillary LN are not palpable, Supraclavicular LN not
palpable
Spinal tenderness – Absent [to look for distant metastasis to spine]
[Left Arm – no edema, no restriction of movement at the shoulder joint]

[Texture and consistency of the breast variable in different females. Palpate the
apparently normal breast first for normal texture/consistency, then compare abnormal
with normal.]

[Methods of Breast Palpation


- Dial clock method
- Quadrant method
- Vertical stripe method
- Horizontal stripe method
- Spoke wheel method]

[Fixity to Muscles:

1. Pectoralis major:
- First, check the fixity of the lump to the muscle when the muscle is relaxed
- If the lump is mobile, ask the patient to press her hands against the waist/hips
- Feel the anterior axillary fold to see if it is taut to make sure that the muscle is
adequately contracting or not
- Check the movement of the lump parallel and perpendicular to the fibres of the
muscle

2. Serratus Anterior
- Look for fixity to serratus anterior in lumps in the Outer Quadrants of the breast
- Ask the patient to stand near a wall and push the wall to check for mobility
- First see mobility in a relaxed position, then in a contracted position

Lump fixity to chest wall:


- On inspection, ask the patient to bend forward. If not falling forward, lump is
fixed to the chest wall
- On palpation- No mobility of the lump even when the muscle is relaxed

Fixed to the chest wall – T4a]

Systemic O/E
- CVS – S1S2 present, no murmur heard
- RS – B/L air entry present. Normal vesicular BS. No added sounds
- CNS- No FND
- P/A – soft, non-tender, no lump or organomegaly, no free fluid

Diagnosis

Provisional Diagnosis: Breast Lump, probably Breast CA with stage cT2N0M0 – Stage
2a. {I would like to do USG to confirm LN status as per 8 th AJCC}
D/d – Phyllodes tumour

[Why CA Breast
- H/o = Age- 48 years, painless, rapidly progressive lump, risk factor – older age
at first live child birth
- O/E – Hard lump, irregular margins, fixed to the skin

[T2: 2-5 cm. In our case, maximum dimension = 5cm


N0: no palpable LN
M0: no c/f s/o metastasis

III
B

Why not Phyllodes tumour – classical features of phyllodes tumour (distended veins)
missing and phyllodes tumour is not fixed to overlying skin
TRUCUT BIOPSY preferred over FNAC
- Basement membrane invasion – in situ vs invasive CA
- Hormonal status of tumour – ER, PR, HER2Neu status
- Grade of tumour
- 14G needle is used, and at least 6 cores of tissue should be taken

Triple assessment – PPV of 99.9%

Core needle biopsy – Invasive Ductal CA? How do you proceed


- Axillary LN status (in N0 patients) – USG Axilla and FNAC (if LN+), OR Sentinel
LN biopsy
- Metastatic workup

Metastatic workup
- Stage 1 and Stage 2 (Early Breast CA)– CBC and LFT
o CT chest + abdomen / Bone scan is needed only if patient is symptomatic
OR abnormality on CBC, LFT detected. E.g. increased ALP on LFT – Bone
scan
- Stage 3 (LABC – risk of occult metastasis is more)
o 3a: CBC, LFT, CT chest + abdomen + pelvis
o 3b and 3c: CBC, LFT, FDG-PET-CT

TREATMENT

Surgery: Early Breast CA


- BCS – if tumour to breast ratio is favourable + sentinel LN Biopsy+ post-op
radiotherapy

C/I of BCS:
- Technical C/I
o Multicentric disease- M/L foci of malignancy involving >1 quadrant of
breast, two tumours/foci of malignancy in same quadrant at > 4 cm
distance
o Tumour breast ratio is not adequate – for adequate margins and cosmesis
o Persistently positive margins [BCS- tumour sent to pathologist – positive
margins – remove margins – again send – positive margins – MRM]
- C/I to radiotherapy:
o 1st and 2nd trimester of pregnancy. In T3, radiotherapy after delivery
o Previous history of radiation to chest wall
o Inflammatory breast CA
o Collagen vascular diseases

Alternatives to BCS
- If patient is N0 – sentinel LN biopsy + simple mastectomy
- N1 – modified radical mastectomy

Structures removed in MRM:


- Entire breast tissue + overlying skin + NAC
- Level 1 and 2 axillary LN +/- Level 3 LN – Minimum 10 LN have to be removed
- Pectoralis minor – either retracted (Aunschinlaus), divided (Scanlon), or removed
(Patey’s)

Adjuvant therapies
- Chemotherapy: Tumour > 1 cm, >0.5 cm with high risk factors, LN positive
o Stage 1, 2 EBC, ER/PR +ve, LN -ve: Gene recurrence score (Oncotype Dx)-
High
o Anthracycline – cyclophosphamide – taxanes sequentially
- Hormonal therapy
o ER/PR +
o Premenopausal – Tamoxifen (SERM); postmenopausal – Letrozole (AI)
- Targeted therapy
o HER2Neu +ve – Transtuzumab

Role of Radiotherapy after MRM


- T3, T4 disease
- > 4 out of 10 LN removed after axillary LN dissection are POSITIVE
- Margins are Positive
- LVI – lymphovascular invasion

All patients after BCS require radiotherapy


After Surgery – tumour removed is sent for HPE – margin status, ER/PR/HER2Neu
status; axillary LN removed are also sent for HPE – LN status (+ or -)

LABC
- Neoadjuvant CT – assessment of response – if response good/complete –
Surgery (MRM).
- If response not good/partial – 1 or 2 more cycles of NACT – MRM – adjuvant
therapy

Advantage of NACT
- Downstages the disease
- In vivo response to chemotherapy – response to CT drugs present or not – can
decide which CT drugs to give for adjuvant CT post MRM

Metastatic Breast CA
- Palliation of symptoms
- Hormonal therapy – ER/PR+
- CT: ER/PR-
- Bony metastasis – HT has good response, Visceral metastasis – CT has good
response
- Bony metastasis – Bisphosphonates can be given. In painful Bony mets. – RT
- Ulcerative/fungating mass – Simple/Toilet mastectomy to improve QoL (palliative
Sx)

Staging of Breast CA:

Stage 1: T1N0

Stage 2: 2A: T1N1, T2N0


2B: T2N1, T3N0

Stage 3: 3A: T3N1, any N2 (T1-3N2)


3B: any T4 (T4N0-2)
3C: any N3 (T1-4N3)

Stage 4: M1

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy